Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey T Vietri

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|May 5, 2016
Missed doses of oral antihyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasonsJeffrey T Vietri, Catherine S Wlodarczyk, Rose Lorenzo, et al.
Multiple Sclerosis International|October 21, 2014
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient SurveyAngela E Williams, Jeffrey T Vietri, Gina Isherwood, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 1, 2011
Vaccinating to help ourselves and othersJeffrey T Vietri, Meng Li, Alison P Galvani, et al.
Infectious Diseases and Therapy|September 25, 2019
Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care ProvidersPatricia Sacco, Kelley Myers, Christine Poulos, et al.
Vaccines|May 25, 2024
Healthcare Providers' and Pregnant People's Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial VirusKathleen M Beusterien, Amy W Law, Martine C Maculaitis, et al.
Human Vaccines & Immunotherapeutics|June 7, 2024
A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United StatesMartine C Maculaitis, Brett Hauber, Kathleen M Beusterien, et al.
The Lancet. Infectious Diseases|May 3, 2026
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort studyAmanda C Miles, Jelena Vojicic, Paula Peyrani, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|May 5, 2016
Missed doses of oral antihyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasonsJeffrey T Vietri, Catherine S Wlodarczyk, Rose Lorenzo, et al.
Multiple Sclerosis International|October 21, 2014
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient SurveyAngela E Williams, Jeffrey T Vietri, Gina Isherwood, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 1, 2011
Vaccinating to help ourselves and othersJeffrey T Vietri, Meng Li, Alison P Galvani, et al.
Infectious Diseases and Therapy|September 25, 2019
Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care ProvidersPatricia Sacco, Kelley Myers, Christine Poulos, et al.
Vaccines|May 25, 2024
Healthcare Providers' and Pregnant People's Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial VirusKathleen M Beusterien, Amy W Law, Martine C Maculaitis, et al.
Human Vaccines & Immunotherapeutics|June 7, 2024
A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United StatesMartine C Maculaitis, Brett Hauber, Kathleen M Beusterien, et al.
The Lancet. Infectious Diseases|May 3, 2026
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort studyAmanda C Miles, Jelena Vojicic, Paula Peyrani, et al.
Pageof 1